Buy Retatrutide 100mg: Triple Agonist Peptide for Advanced Metabolic Research

Retatrutide (100mg) is a next-generation triple hormone receptor agonist that simultaneously activates GLP-1, GIP, and glucagon receptors. This high-capacity 100mg vial is designed for advanced laboratory use, offering researchers greater flexibility for high-dose, long-term, or bulk reconstitution studies. Retatrutide is one of the most potent peptides currently studied for substantial weight loss, appetite suppression, energy expenditure, glucose control, and fat metabolism in obesity and type 2 diabetes models.

Molecular Formula: C₂₂₁H₃₄₂N₄₆O₆₈ Molecular Weight: 4813.5 g/mol (approximate) Purity: ≥99% (lyophilized, research-grade)

Important Notice: This peptide is strictly intended for research and laboratory use only. Not for human consumption, diagnostic, therapeutic, or veterinary purposes. Please review and agree to our Terms and Conditions before ordering.

What is Retatrutide?

Retatrutide is a synthetic multi-agonist peptide engineered to target three metabolic hormone pathways at once:

• GLP-1 receptor — for appetite suppression and glucose-dependent insulin secretion
• GIP receptor — for improved insulin sensitivity and lipid metabolism
• Glucagon receptor — for increased energy expenditure and lipolysis

This triple mechanism provides more comprehensive metabolic effects than dual agonists like tirzepatide, making Retatrutide a leading compound in current incretin and obesity research.

Mechanism of Action in Research

In experimental models, Retatrutide:

• Strongly reduces appetite and caloric intake
• Boosts energy expenditure through glucagon receptor activation
• Promotes significant reduction in body weight and visceral fat
• Enhances insulin sensitivity and glycemic control
• Improves lipid profiles and overall cardiometabolic markers

Research indicates Retatrutide may achieve superior weight loss outcomes compared to current dual GLP-1/GIP agonists.

Key Research Areas

The 100mg format is particularly suited for:

• High-dose and chronic administration studies
• Long-term obesity and metabolic disease models
• Bulk reconstitution and stability testing
• Comparative triple vs. dual agonist research
• Energy balance, thermogenesis, and body composition analysis

Research Applications

The 100mg vial supports:

• Dose-response and extended metabolic studies
• Large-scale animal models of obesity and type 2 diabetes
• Body composition and fat mass quantification
• Pharmacokinetic and long-term efficacy experiments
• Comparative multi-receptor agonist investigations

Why Choose 99% Pure Retatrutide 100mg?

Our Retatrutide 100mg delivers ≥99% purity for reliable, reproducible results in receptor activation, appetite regulation, and metabolic outcome studies. Third-party tested and lyophilized for optimal stability in advanced research settings.

In summary, Retatrutide 100mg is a high-capacity triple agonist peptide ideal for advanced research into weight loss, obesity, glucose control, energy expenditure, and metabolic health. Scale up your incretin and multi-agonist studies with this premium research tool.